Latest Blog Posts

Generic Drugs May Not Be as Effective or Safe as Name-Brand Medications

by Staff Blogger | July 16th, 2019

Prescription medications are often extremely expensive, especially for patients without insurance that covers them. The cost of many prescription drugs causes patients to turn to generic medications, which are legally required to be virtually identical in chemical composition and ingredients. However, many generic drugs are manufactured overseas in plants with little to no oversight or

Read More

FDA Announces Class I Recall of Defective Surgical Stapler and Staples

by Staff Blogger | July 9th, 2019

In April 2019, we discussed the U.S. Food and Drug Administration’s (FDA) findings of serious injuries and even deaths related to malfunctioning surgical staplers and misapplied surgical staples. In May 2019, the FDA announced that Ethicon was recalling its circular staplers due to their tendency to misfire and to fail to completely form staples, both

Read More

Class of Diabetes Drugs Linked to Potentially Fatal Genital Infection

by Staff Blogger | July 2nd, 2019

In August 2018, the U.S. Food and Drug Administration (FDA) warned the public and healthcare providers about the risk of a class of type 2 diabetes medications called sodium-glucose cotransporter-2 (SGLT2) inhibitors causing a rare and potentially life-threatening genital infection called Fournier’s gangrene. Medications in that class of drugs include: Farxiga (dapagliflozin) Xigduo XR (dapagliflozin/metformin)

Read More

Oklahoma Attorney General Sues Johnson & Johnson for Its Part in Opioid Epidemic

by Staff Blogger | June 25th, 2019

Oklahoma’s attorney general is suing billion-dollar corporation Johnson & Johnson for its alleged role in fueling the state’s opioid epidemic and for downplaying the risks of its opioid painkillers. According to ABC News, two other pharmaceutical companies that are defendants in the lawsuit have already settled with Oklahoma. Teva Pharmaceuticals agreed to pay $85 million

Read More